OR WAIT null SECS
August 13, 2021
Almac Sciences has signed a manufacturing agreement with Pila Pharma for the production of the API XEN-D0501.
Recro acquires CDMO IRISYS, establishing a bi-coastal presence in the US.
August 12, 2021
Veraxa and Indivumed will work together to develop colorectal antibody drugs.
August 09, 2021
Kyowa Pharmaceutical Industry and Bora Pharmaceuticals have announced a partnership to produce generic-drug product for filing in Japan.
August 06, 2021
Syngene International appoints two US-based executives to senior level positions.
July 30, 2021
VICO Therapeutics’ drug candidate, VO659, for treating Huntington’s Disease was granted orphan drug designation by FDA.
June 02, 2021
Expanded interest in advanced drug manufacturing and continuous production methods calls for more flexible production systems and regulatory policies.
May 25, 2021
Evonik has introduced the EUDRACAP, a portfolio of easy-to-handle capsules to fast-track speed to market for oral drug products in the early development stage.
May 10, 2021
BioNTech plans to expand its global footprint by establishing its regional headquarters for southeast Asia and a new mRNA manufacturing facility in Singapore.
March 30, 2021
The expanded agreement will include aseptic fill/finish services at its San Diego, CA facility.